CCM
CLVS

Cupps Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Cupps Capital Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-28,422
Closed -$2.61M – 202
2015
Q3 		$2.61M Buy
+28,422
New +$2.46M 0.35% 87

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cupps Capital Management's CLVS Position: Q4 2015 in Review

Cupps Capital Management sold out of Clovis Oncology, Inc. (CLVS) in Q4 2015, closing a stake of 28,422 shares — an estimated $2.61M sold.

Cupps Capital Management first reported a position in CLVS in Q3 2015 and held it in 1 quarter. The position peaked at $2.61M in Q3 2015. 157 funds tracked by Wall St. Rank hold CLVS as of Q4 2015.

  • Cupps Capital Management reported no remaining Clovis Oncology, Inc. position as of Q4 2015 after selling out during the quarter.
  • Cupps Capital Management sold 28,422 Clovis Oncology, Inc. shares in Q4 2015, an estimated $2.61M.
  • Cupps Capital Management first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 1 quarter.
  • Cupps Capital Management's Clovis Oncology, Inc. position peaked at $2.61M in Q3 2015.
  • 157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2015.

Based on Cupps Capital Management's 13F filing for Q4 2015, filed 11 Feb 2016.